bioAffinity Technologies
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIAF and other ETFs, options, and stocks.About BIAF
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells.
BIAF Key Statistics
Stock Snapshot
The current bioAffinity Technologies(BIAF) stock price is $1.27, with a market capitalization of 5.85M. The stock trades at a price-to-earnings (P/E) ratio of -0.06.
On 2025-12-23, bioAffinity Technologies(BIAF) stock moved within a range of $1.23 to $1.35. With shares now at $1.27, the stock is trading +3.6% above its intraday low and -6.0% below the session's peak.
Trading activity shows a volume of 9.55K, compared to an average daily volume of 62.25K.
The stock's 52-week range extends from a low of $1.18 to a high of $46.53.
The stock's 52-week range extends from a low of $1.18 to a high of $46.53.
BIAF News
Claim 70% Off TipRanks This Holiday Season bioAffinity Technologies, Inc. ( (BIAF) ) has provided an announcement. On September 18, 2023, bioAffinity Technolo...
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...